Genmab — Juni 2023
-
Genmab : Det undrer mig at der ikke er hyppigere omtale af en værdi sammenligning med hvad Segan blev solgt for til Pfizer idet hvis jeg husker rigtigt så svarer Segans salgspris til at Genmab med samme værdisætning skulle være ca det dobbelte værd ?
-
Ikke kun JWs beslutning, men ja, der kommer vel også (snart?) en dag hvor der skal en ny CEO på banen og det ville være rart med lidt til pensionen
https://medwatch.dk/Mennesker/article15440176.ece -
innovaTV 207 adjusted a bit, 3 more arms, 30% more patients https://classic.clinicaltrials.gov/ct2/history/NCT03485209?A=71&B=72&C=Side-by-Side#StudyPageTop
-
the trial Epcoritamab and Rituximab for First-line Follicular Lymphoma starts recruiting, just after the data we just saw on mono in later lines https://classic.clinicaltrials.gov/ct2/history/NCT05783609?B=2&A=1&C=merged#StudyPageTop
-
MET Overexpression as a Predictive Biomarker in Post-Osimertinib NSCLC https://www.targetedonc.com/view/met-overexpression-as-a-predictive-biomarker-in-post-osimertinib-nsclc
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind